Accent Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-29
Closed -$3.61K – 417
2025
Q2
$3.61K Hold
29
– – ﹤0.01% 357
2025
Q1
$3.69K Buy
+29
New +$4.46K ﹤0.01% 276

Other funds holding RGEN

Accent Capital Management's RGEN Position: Q3 2025 in Review

Accent Capital Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 29 shares — an estimated $3.61K sold.

Accent Capital Management first reported a position in RGEN in Q1 2025 and held it in 2 quarters. The position peaked at $3.69K in Q1 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Accent Capital Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Accent Capital Management sold 29 Repligen shares in Q3 2025, an estimated $3.61K.
  • Accent Capital Management first reported a position in Repligen in Q1 2025 and held it in 2 quarters.
  • Accent Capital Management's Repligen position peaked at $3.69K in Q1 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Accent Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.